Table 4.
Any |
Grade-1 |
Grade-2 |
|||||
---|---|---|---|---|---|---|---|
time point | group | n(%) | P | n(%) | P | n(%) | P |
30min | Placebo(n = 40) | 1(2.50) | 0.772 | 1(2.50) | 0.772 | 0 | NA |
Low-dose(n = 40) | 2(5.00) | 2(5.00) | 0 | ||||
High-dose(n = 40) | 0 | 0 | 0 | ||||
6h | Placebo(n = 40) | 8(20.00) | 0.098 | 8(20.00) | 0.161 | 0 | 1.000 |
Low-dose(n = 40) | 3(7.50) | 3(7.50) | 0 | ||||
High-dose(n = 40) | 10(25.00) | 9(22.50) | 1(2.50) | ||||
day1(24h) | Placebo(n = 40) | 1(2.50) | 0.006 | 1(2.50) | 1.000 | 0 | 0.003 |
Low-dose(n = 40) | 0 | 0 | 0 | ||||
High-dose(n = 40) | 7(17.50) | 1(2.50) | 6(15.00) | ||||
day2 | Placebo(n = 40) | 1(2.50) | 0.617 | 1(2.50) | 1.000 | 0 | 0.328 |
Low-dose(n = 40) | 1(2.50) | 1(2.50) | 0 | ||||
High-dose(n = 40) | 3(7.50) | 1(2.50) | 2(5.00) | ||||
day3 | Placebo(n = 40) | 2(5.00) | 0.544 | 2(5.00) | 0.544 | 0 | NA |
Low-dose(n = 40) | 2(5.00) | 2(5.00) | 0 | ||||
High-dose(n = 40) | 0 | 0 | 0 | ||||
day4 | Placebo(n = 40) | 1(2.50) | 1.000 | 1(2.50) | 1.000 | 0 | NA |
Low-dose(n = 40) | 1(2.50) | 1(2.50) | 0 | ||||
High-dose(n = 40) | 0 | 0 | 0 | ||||
day5 | Placebo(n = 40) | 1(2.50) | 1.000 | 1(2.50) | 1.000 | 0 | NA |
Low-dose(n = 40) | 1(2.50) | 1(2.50) | 0 | ||||
High-dose(n = 40) | 1(2.50) | 1(2.50) | 0 | ||||
day6 | total | 0 | NA | 0 | NA | 0 | NA |
day7 | total | 0 | NA | 0 | NA | 0 | NA |